COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
72.92 EUR
-0.94 (-1.27%)
CBHD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. CBHD has an excellent profitability rating, but there are some minor concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively. CBHD also has an excellent dividend rating. These ratings would make CBHD suitable for dividend investing!
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
CBHD had a positive operating cash flow in the past year.
In the past 5 years CBHD has always been profitable.
CBHD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CBHD's Return On Assets of 7.52% is amongst the best of the industry. CBHD outperforms 81.54% of its industry peers.
The Return On Equity of CBHD (22.55%) is better than 89.23% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.65%, CBHD belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CBHD is above the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
The Profit Margin of CBHD (13.04%) is better than 73.85% of its industry peers.
In the last couple of years the Profit Margin of CBHD has declined.
Looking at the Operating Margin, with a value of 27.52%, CBHD belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
In the last couple of years the Operating Margin of CBHD has declined.
CBHD has a Gross Margin of 67.97%. This is in the better half of the industry: CBHD outperforms 73.85% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
Compared to 1 year ago, CBHD has about the same amount of shares outstanding.
CBHD has more shares outstanding than it did 5 years ago.
CBHD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.84 indicates that CBHD is not in any danger for bankruptcy at the moment.
The Altman-Z score of CBHD (3.84) is better than 69.23% of its industry peers.
CBHD has a debt to FCF ratio of 4.34. This is a neutral value as CBHD would need 4.34 years to pay back of all of its debts.
CBHD has a Debt to FCF ratio of 4.34. This is comparable to the rest of the industry: CBHD outperforms 58.46% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that CBHD has dependencies on debt financing.
CBHD has a Debt to Equity ratio of 1.24. This is amonst the worse of the industry: CBHD underperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.84 |
ROIC/WACC2.22
WACC5.69%
2.3 Liquidity
A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
CBHD has a Current ratio (1.61) which is in line with its industry peers.
A Quick Ratio of 1.00 indicates that CBHD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, CBHD is in line with its industry, outperforming 41.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -20.93% in the last year.
CBHD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.02% yearly.
Looking at the last year, CBHD shows a small growth in Revenue. The Revenue has grown by 3.12% in the last year.
The Revenue has been growing by 8.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
CBHD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.78% yearly.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 7.08% on average per year.
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 30.64, CBHD can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as CBHD.
The average S&P500 Price/Earnings ratio is at 26.59. CBHD is around the same levels.
CBHD is valuated rather expensively with a Price/Forward Earnings ratio of 20.88.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBHD is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CBHD to the average of the S&P500 Index (24.03), we can say CBHD is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.64 | ||
| Fwd PE | 20.88 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CBHD.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 76.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.94 | ||
| EV/EBITDA | 14.93 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CBHD may justify a higher PE ratio.
CBHD's earnings are expected to grow with 21.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y27.18%
EPS Next 3Y21.46%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 4.23%, which is a nice return.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 1.03. CBHD pays more dividend than 98.46% of the companies in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.23% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
136.36% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP136.36%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
FRA:CBHD (12/23/2025, 7:00:00 PM)
72.92
-0.94 (-1.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap15.33B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70
Price Target92.6 (26.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.23% |
Yearly Dividend2.94
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)0.64%
PT rev (3m)-2.26%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)17.67%
EPS NY rev (1m)0.81%
EPS NY rev (3m)-2.74%
Revenue NQ rev (1m)2.61%
Revenue NQ rev (3m)8.83%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.64 | ||
| Fwd PE | 20.88 | ||
| P/S | 4.11 | ||
| P/FCF | 21.94 | ||
| P/OCF | 17.23 | ||
| P/B | 7.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.93 |
EPS(TTM)2.38
EY3.26%
EPS(NY)3.49
Fwd EY4.79%
FCF(TTM)3.32
FCFY4.56%
OCF(TTM)4.23
OCFY5.8%
SpS17.75
BVpS10.27
TBVpS-8.72
PEG (NY)0.65
PEG (5Y)N/A
Graham Number23.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.84 |
F-Score6
WACC5.69%
ROIC/WACC2.22
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.63%
EBIT Next 3Y14.66%
EBIT Next 5Y12.28%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.87% in the next year.